We are live on ! Find out more
ADVM icon

Adverum Biotechnologies

Delisted

ADVM was delisted on the 8th of December, 2025.

84 hedge funds and large institutions have $727M invested in Adverum Biotechnologies in 2014 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 29 increasing their positions, 14 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

386% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 7

130% more capital inflows, than outflows

Capital inflows: $68.9M | Capital outflows: $29.9M

107% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 14

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

45% more funds holding

Funds holding: 58 → 84 (+26)

2.69% less ownership

Funds ownership: 56.27% → 53.59% (-2.7%)

Holders
84
Holders Change
+26
Holders Change %
+44.83%
% of All Funds
2.23%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.11%
New
34
Increased
29
Reduced
14
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

ADVM Hedge Fund Activity: Q4 2014 in Review

84 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Adverum Biotechnologies (ADVM) for Q4 2014, worth a combined $727M — up 73% from $420M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new ADVM positions and 7 closed out — a net gain of 27 holders — while 29 added to existing stakes and 14 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $11M. The largest seller was Deerfield Management, cutting an estimated $16.7M.

  • 84 institutional investors held Adverum Biotechnologies (ADVM) as of Q4 2014, up from 58 in Q3 2014.
  • Funds reported $727M of Adverum Biotechnologies stock for Q4 2014, up 73% quarter-over-quarter.
  • 34 funds opened new Adverum Biotechnologies positions in Q4 2014 and 7 closed out, a net change of +27 holders.
  • The largest Adverum Biotechnologies buyer in Q4 2014 was BlackRock Fund Advisors, an estimated $11M added.
  • The largest Adverum Biotechnologies seller in Q4 2014 was Deerfield Management, an estimated $16.7M sold.

Based on aggregated 13F filings for Q4 2014.